MyFinsight
Home
Blog
About
Contact
Download
Download image
Depreciation of fixed assets
and amortization of...
$91,023K
Stock-based compensation
$57,502K
Indefinite-lived intangible
asset impairment
$25,866K
Sales of
available-for-sale investments
$273,807K
Investment impairment
$11,000K
Net income (loss)
$7,034K
Accrued expenses and
other liabilities
$6,853K
Deferred taxes
$6,477K
Amortization of debt issuance
costs and debt...
$2,997K
Loss (gain) on early
extinguishment of debt
-$983K
Net cash provided by
operating activities
$151,994K
Net cash provided by
(used in) investing...
$99,481K
Canceled cashflow
$57,741K
Canceled cashflow
$174,326K
Net (decrease)
increase in cash and cash...
-$118,229K
Canceled cashflow
$251,475K
Proceeds from revolving
credit facility
$101,000K
Proceeds from shares
issued under employee...
$2,801K
Proceeds from exercises
of stock options
$502K
Inventories, net
$27,567K
Accounts receivable, net
$10,742K
Accounts payable
-$5,598K
Other net (gains)
losses
-$5,520K
Net accretion of
discount on...
$4,927K
Changes in contingent
consideration
-$2,175K
Prepaid expenses and
other assets
$1,212K
Purchases of
available-for-sale investments
$141,041K
Acquisition of gq bio
therapeutics gmbh (net of cash...
$16,702K
Purchases of fixed assets
$15,333K
Purchases of debt and
equity investments
$1,250K
Net cash (used in)
provided by financing...
-$369,627K
Canceled cashflow
$104,303K
Effect of exchange rate
changes on cash and cash...
-$77K
Repayments of convertible
senior...
$202,487K
Purchase of treasury
stock, inclusive of...
$148,328K
Repayment of term loan
facility-Term Loan AFacility
$105,312K
Repayment of revolving
credit facility
$10,000K
Payment of employee
withholding taxes on...
$5,617K
Payment of debt issuance
and financing costs
$2,186K
Back
Back
Cash Flow
source: myfinsight.com
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)